| Strategies for characterizing sildenafil, vardenafil, tadalafil and their analogues in herbal dietary supplements, and detecting counterfeit products containing these drugs S Singh, B Prasad, AA Savaliya, RP Shah, VM Gohil, A Kaur TrAC Trends in Analytical Chemistry 28 (1), 13-28, 2009 | 209 | 2009 |
| Modulating TNF-α signaling with natural products AT Paul, VM Gohil, KK Bhutani Drug discovery today 11 (15-16), 725-732, 2006 | 178 | 2006 |
| Natural products drug discovery research in India: Status and appraisal KK Bhutani, VM Gohil Indian journal of experimental biology 48 (03), 199-207, 2010 | 159 | 2010 |
| Design, synthesis and biological evaluation of 1, 3, 6-trisubstituted β-carboline derivatives for cytotoxic and anti-leishmanial potential NA Lunagariya, VM Gohil, V Kushwah, S Neelagiri, S Jain, S Singh, ... Bioorganic & Medicinal Chemistry Letters 26 (3), 789-794, 2016 | 46 | 2016 |
| Synthesis and anti-leishmanial activity of 1-aryl-β-carboline derivatives against Leishmania donovani VM Gohil, KG Brahmbhatt, PM Loiseau, KK Bhutani Bioorganic & Medicinal Chemistry Letters 22 (12), 3905-3907, 2012 | 42 | 2012 |
| Synthesis, biological evaluation and molecular docking of aryl hydrazines and hydrazides for anticancer activity VM Gohil, SK Agrawal, AK Saxena, D Garg, C Gopimohan, KK Bhutani CSIR, 2010 | 16 | 2010 |
| Safety, tolerability and pharmacokinetics (pk) of single and multiple doses of alg-010133, an s-antigen transport inhibiting oligonucleotide polymer (stops) for the treatment … E Gane, MF Yuen, J Yogaratnam, K Le, J Vuong, W Christopher, V Gohil, ... J Hepatol 75 (Suppl), S741, 2021 | 7 | 2021 |
| THE S-ANTIGEN TRANSPORT-INHIBITING OLIGONUCLEOTIDE POLYMER (STOPS™) ALG-010133 DEMONSTRATES A FAVORABLE PRECLINICAL PROFILE FOR THE TREATMENT OF CHRONIC HEPATITIS B V Gohil, D Misner, S Chanda, Q Zhang, J Liu, J Hong, R Pandey, ... Liver 91 (15.7), 930, 2020 | 4 | 2020 |
| Safety, pharmacokinetics, and antiviral activity of the S-antigen Transport Inhibiting Oligonucleotide Polymers (STOPS) drug candidate ALG-010133 in subjects with chronic … EJ Gane, K Agarwal, MF Yuen, A Jucov, C Schwabe, K Le, S Wang, ... Journal of Hepatology, S871-S872, 2022 | 2 | 2022 |
| THU-198 In vitro and in vivo pharmacological characterization of human PNPLA3-targeting short interfering RNA molecules for the treatment of metabolic dysfunction-associated … J Song, J Deval, L Adame, R Jaisinghani, E Tso, D Lin, A Bhattacharya, ... Journal of Hepatology 80, S564-S565, 2024 | | 2024 |
| An in vivo duck hepatitis B virus model recapitulates key aspects of nucleic acid polymer treatment outcomes in chronic hepatitis B patients Y Debing, H Vanrusselt, L Degrauwe, DAS de Oliveira, CK Kariuki, ... Antiviral Research, 105835, 2024 | | 2024 |
| Best-in-Class Antisense Oligonucleotides Against Hepatitis B Virus Using Next Generation Bridged Nucleic Acid Chemistries Significantly Increases In Vivo Efficacy and Reduces … D Misner, J Hong, B Filippi, S Chang, M Tu, G Wiki, F Wenz, K Gupta, ... INTERNATIONAL JOURNAL OF TOXICOLOGY 42 (1), 94-94, 2023 | | 2023 |
| Lack of Translation of Favorable Nonclinical Toxicology Profile of Antisense Oligonucleotide (ASO) ALG-020572 to Chronic Hepatitis B (CHB) Patients S Chang, D Misner, K Gupta, G Gratz, J Hong, K Le, V Gohil, ... INTERNATIONAL JOURNAL OF TOXICOLOGY 42 (1), 89-90, 2023 | | 2023 |
| Nonclinical efficacy, pharmacokinetic profile and pharmacokinetic/pharmacodynamic (PK/PD) correlation of ALG-125755, a GalNAc-conjugated siRNA, for functional cure of chronic … K Gupta, M Fitzgerald, K Le, V Gohil, S Mukherjee, D Misner, J Hong, ... ratio 6245, 0.01, 2022 | | 2022 |
| Safety, pharmacokinetics, and antiviral activity of the S-antigen Transport Inhibiting Oligonucleotide Polymers (STOPS) drug candidate ALG-010133 in subjects with chronic … EJ Gane, K Agarwal, RMF Yuen, A Jucov, C Schwabe, K Le, S Wang, ... The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology, 2022 | | 2022 |
| ALG-020572, a GalNAc-conjugated Antisense Oligonucleotide, Demonstrates In Vivo Efficacy and Favorable Preclinical Profile for the Treatment of Chronic Hepatitis B K Gupta, J Hong, K Le, D Misner, V Gohil, H Tan, H Kang, M Luo, ... HEPATOLOGY 74, 503A-503A, 2021 | | 2021 |
| Quantitation of siRNA in Biological Matrices by Liquid Chromatography and High Resolution Accurate Mass Spectrometry (LC/MS-HRAM) SW Yuanxin Xu Ju Liu, Krishna Aluri, Vikrant Gohil, Chris Tran, Jing Li ASMS Conference on Mass Spectrometry and Allied Topics 65, 2017 | | 2017 |
| Top-Down Analysis of Penicillin Binding Protein 2a from Methicillin Resistant Staphlococcus Aureus J Neil, H Cardasis, P Yip, V Gohil, A Cherkassky, J Stephenson ASMS Conference on Mass Spectrometry and Allied Topics, 2015 | | 2015 |
| Pharmaceutical Biotechnology and Biopharmaceuticals A Paul, V Gohil, K Bhutani A Textbook of Molecular Biotechnology, 735-762, 2009 | | 2009 |
| Development of an All-Recombinant Intact Protein Standard for LC-MS Application Development and System Suitability Testing HL Cardasis, R Viner, V Gohil, K Opperman, S Bechler, J Rogers, K Flook, ... proteins 1009, 8, 0 | | |
K. K. BhutaniProfessor, National Institute of Pharmaceutical Education and Research在 niper.ac.in 的电子邮件经过验证
